Strategy | UITRI
Current context and strategic importance
The current phase of recovery from the COVID‑19 pandemic makes it even more necessary to strengthen R&D&I support structures, ensuring flexible units capable of adapting to technological progress in scientific environments. For this reason, the IdISBa Innovation Unit must play a key role in structuring the public R&D&I system across the Balearic Islands, a region geographically distant and with limited critical mass compared to the main scientific-technical hubs in Spain.
The UITRI must foster coordination and synergies with these knowledge hubs, improving and facilitating the development of innovation and transfer activities, boosting the region's economy, and ensuring that these innovative solutions achieve real impacts on population health.
Effective coordination among all entities within IdISBa in the processes of identifying, evaluating, valorising, protecting, and commercialising innovative initiatives and projects is essential to achieve impactful results. This defines an innovation cycle within the clinical and biomedical environment that enhances collaboration between public and private institutions, contributes to cost-efficiency in clinical processes, and improves patients' quality of life.
Current situation and strategic role of UITRI
The end of the COVID-19 pandemic makes it even more necessary to strengthen R&D&I support structures, having flexible units capable of adapting to the technological progress of scientific environments.
UITRI must play a key role in the structuring of the public R&D&I system in the Balearic Islands, a territory far from the main scientific and technical hubs of the State, both geographically and by critical mass.
Coordination between all the entities that make up the IdISBa in the processes of identification, evaluation, valorization, protection and technological commercialization is essential to obtain impactful results, define a solid innovation cycle in the clinical and biomedical environment and contribute to the cost-efficiency balance of clinical processes and the improvement of the quality of life of patients.